• Science & Technology

Combining images and genetic data proves gene loss behind aggressive ovarian cancers

Scientists have shown that loss of a gene called PTEN  triggers some cases of an aggressive form of ovarian cancer. Scientists have shown that loss of a gene called PTEN  triggers some cases of an aggressive form of ovarian cancer.

17 December 2014

• Health & Medicine
• Science & Technology

Coming ever closer – first PARP inhibitor licensed in Europe

Olaparib is the first PARP inhibitor to move closer to licensing in Europe. What is it, how does it work, and when will it be available in the UK? Olaparib is the first PARP inhibitor to move closer to licensing in Europe. What is it, how does it work, and when will it be available in the UK?

24 October 2014

• Health & Medicine
• Science & Technology

A year of research - and 13 milestones you helped fund

To coincide with the publication of our Annual Review, here are some of the key research milestones that our amazing supporters have helped fund. To coincide with the publication of our Annual Review, here are some of the key research milestones that our amazing supporters have helped fund.

25 July 2014

• Health & Medicine

New drug extends life in women with advanced ovarian cancer

Women with ovarian cancer that returned after treatment had their life extended by almost three months after treatment with the drug cediranib. Women with ovarian cancer that returned after treatment had their life extended by almost three months after treatment with the drug cediranib.

5 November 2013

• Health & Medicine

New research shows ‘DNA tags’ could guide treatment for advanced ovarian cancer

A Cancer Research UK study has identified chemical 'tags' on DNA in patients’ tumours that could help doctors decide the type of chemotherapy women with advanced ovarian cancer should receive, according to a new paper published in the journal Clinical Cancer Research. A Cancer Research UK study has identified chemical 'tags' on DNA in patients’ tumours that could help doctors decide the type of chemotherapy women with advanced ovarian cancer should receive, according to a new paper published in the journal Clinical Cancer Research.

15 October 2013

Scientists find new gene linked to ovarian cancer

Cancer Research UK scientists have found a gene in mice that could protect against ovarian cancer and, if faulty, may increase the chance of developing the disease, according to research published in Nature. Cancer Research UK scientists have found a gene in mice that could protect against ovarian cancer and, if faulty, may increase the chance of developing the disease, according to research published in Nature.

4 September 2013

• Science & Technology

Building an artificial tumour in the lab

16 May 2013

• Health & Medicine
• Science & Technology

Watching cancers evolve using ‘liquid biopsies’

Tumours release DNA into the bloodstream, and scientists have been investigating whether this could offer clues about a cancer - take a look at what they found. Tumours release DNA into the bloodstream, and scientists have been investigating whether this could offer clues about a cancer - take a look at what they found.

8 April 2013

• Health & Medicine

Scientists develop simple blood test to track tumour evolution in cancer patients

Scientists have developed a new way of looking at how tumours evolve in real-time and develop drug resistance by tracking changes in blood. Scientists have developed a new way of looking at how tumours evolve in real-time and develop drug resistance by tracking changes in blood.

7 April 2013

• Health & Medicine
• Science & Technology

Gene variations and cancer risk – more results, more answers and more questions

27 March 2013

• Health & Medicine
• Science & Technology

Study reveals the genetic variations that raise the risk of breast, prostate or ovarian cancer

80+ regions of the genome that can increase an individual's risk of breast, prostate and ovarian cancers have been found in the largest ever... 80+ regions of the genome that can increase an individual's risk of breast, prostate and ovarian cancers have been found in the largest ever...

27 March 2013

• Health & Medicine

Chemo given into the abdomen could boost ovarian cancer survival

Chemotherapy given straight into the abdomen of certain ovarian cancer patients could allow them to live an extra three years on average, according to new research published in the British Journal of Cancer. Chemotherapy given straight into the abdomen of certain ovarian cancer patients could allow them to live an extra three years on average, according to new research published in the British Journal of Cancer.

6 March 2013